{"id":"https://openalex.org/W2896464239","doi":"https://doi.org/10.1016/j.jalz.2018.06.2594","title":"P4\u2010189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF A\u03b240 LEVELS IN PLASMA","display_name":"P4\u2010189: ABVAC40 TREATMENT IN DOGS INDUCES SPECIFIC ANTIBODY RESPONSE AND INCREMENT OF A\u03b240 LEVELS IN PLASMA","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2896464239","doi":"https://doi.org/10.1016/j.jalz.2018.06.2594","mag":"2896464239"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2018.06.2594","doi":"https://doi.org/10.1016/j.jalz.2018.06.2594","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.2594","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025824466","display_name":"Ana Ma Lacosta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ana M. Lacosta","raw_affiliation_strings":["Araclon Biotech, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Araclon Biotech, Zaragoza, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008503455","display_name":"Noelia Fandos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noelia Fandos","raw_affiliation_strings":["Araclon Biotech, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Araclon Biotech, Zaragoza, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004584329","display_name":"Virginia P\u00e9rez\u2010Grijalba","orcid":"https://orcid.org/0000-0002-7062-827X","observed_orcids":["https://orcid.org/0000-0002-7062-827X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Virginia P\u00e9rez-Grijalba","raw_affiliation_strings":["Araclon Biotech, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Araclon Biotech, Zaragoza, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058223155","display_name":"Pedro Pesini","orcid":"https://orcid.org/0000-0002-0656-2384","observed_orcids":["https://orcid.org/0000-0002-0656-2384"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Pesini","raw_affiliation_strings":["Araclon Biotech, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Araclon Biotech, Zaragoza, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111652125","display_name":"Manuel Sarasa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manuel Sarasa","raw_affiliation_strings":["Araclon Biotech, Zaragoza, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Araclon Biotech, Zaragoza, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5025824466"],"corresponding_institution_ids":[],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.09731106,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7S_Part_29","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyloid-beta-40","display_name":"A\u03b240","score":0.7360000014305115}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7409636974334717},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6708178520202637},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.648045539855957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6454691886901855},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6411459445953369},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6397494673728943},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.5741370916366577},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.488205224275589},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48471832275390625},{"id":"https://openalex.org/C22889606","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Antibody titer","level":4,"score":0.48297300934791565},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38356417417526245},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18104588985443115},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12636330723762512},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2018.06.2594","doi":"https://doi.org/10.1016/j.jalz.2018.06.2594","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.2594","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1994413498","https://openalex.org/W2155138204","https://openalex.org/W2079252398","https://openalex.org/W1970650461","https://openalex.org/W6902382198","https://openalex.org/W2032365749","https://openalex.org/W2087036734","https://openalex.org/W2789484532","https://openalex.org/W2002429040","https://openalex.org/W2533469583"],"abstract_inverted_index":{"Canines":[0],"may":[1],"suffer":[2],"a":[3,14,37,241,325,337],"syndrome":[4],"of":[5,18,36,44,124,143,158,165,172,181,238,253,306,313,322],"cognitive":[6],"dysfunction":[7],"associated":[8],"with":[9,94,178,308],"aging":[10],"that":[11],"is":[12,58,79,169],"considered":[13],"natural":[15],"(non-transgenic)":[16],"model":[17],"Alzheimer's":[19],"Disease":[20],"which":[21,64,189,332],"has":[22,65],"been":[23],"used":[24],"to":[25,48,175,184,247,284],"test":[26],"several":[27],"amyloid":[28],"targeting":[29],"therapies.":[30],"Here":[31],"we":[32],"present":[33],"the":[34,156,162,170,179,185,196,205,216,227,274,285,295,302,311,319],"results":[35,68],"randomised,":[38],"double-blind,":[39],"placebo-controlled,":[40],"parallel":[41],"group":[42],"study":[43],"ABvac40":[45,57,78,96,217,230,309,336],"in":[46,53,69,82,101,134,139,167,200,207,215,294,301],"dogs":[47,90,228,307],"assess":[49],"immunogenicity":[50],"and":[51,86,105,116,121,137,145,210,218,317,343],"changes":[52,293],"plasma":[54,135,140,168,176,297,320],"A\u03b2":[55,166,296],"biomarkers.":[56],"an":[59],"active":[60],"vaccine":[61,335],"against":[62],"A\u03b240":[63,144,323],"shown":[66],"favourable":[67],"Phase":[70,73],"I.":[71],"A":[72],"II":[74],"clinical":[75],"trial":[76],"on":[77,111,328],"currently":[80],"ongoing":[81],"France,":[83],"Italy,":[84],"Spain":[85],"Sweden.":[87],"Twelve":[88],"young":[89],"were":[91,109,128,147,221,255,299],"subcutaneously":[92],"injected":[93],"either":[95],"(N=8)":[97],"or":[98],"placebo":[99,219,303],"(n=4)":[100],"days":[102,112],"D0,":[103],"D14":[104],"D28.":[106],"Blood":[107],"samples":[108],"collected":[110],"D0":[113],"(before":[114],"vaccination),":[115],"D7,":[117],"D21,":[118,236],"D35,":[119],"D42":[120],"D56.":[122],"Levels":[123,252],"specific":[125,186,232,289,315],"anti-A\u03b240":[126,187,233,290,314],"antibodies":[127,188,291,316],"assessed":[129],"by":[130,193,223],"titration":[131],"ELISAs.":[132],"Free":[133],"(FP)":[136],"total":[138],"(TP)":[141],"levels":[142,212,237,249,298,321],"A\u03b242":[146],"quantified":[148],"using":[149],"ABtest":[150],"(Araclon":[151],"Biotech,":[152],"Zaragoza,":[153],"Spain).":[154],"In":[155,272],"context":[157],"this":[159],"immunization":[160],"experiment,":[161],"TP":[163],"level":[164],"amount":[171],"peptide":[173,197,211],"bound":[174,183],"components,":[177],"exclusion":[180],"those":[182],"probably":[190],"escape":[191],"detection":[192],"ABtest,":[194],"plus":[195],"found":[198],"free":[199],"plasma.":[201],"At":[202,235],"each":[203],"visit,":[204],"increment":[206],"antibody":[208],"titers":[209],"from":[213,280],"baseline":[214],"groups":[220],"compared":[222,283],"Mann-Whitney":[224],"test.":[225],"All":[226],"receiving":[229],"developed":[231],"antibodies.":[234],"FP40":[239,270],"experienced":[240],"substantial":[242],"but":[243],"transient":[244],"increase,":[245],"returning":[246],"pre-immune":[248,286],"at":[250,259],"D35.":[251],"TP40":[254],"also":[256],"dramatically":[257],"increased":[258],"D21":[260,281],"but,":[261],"interestingly,":[262],"they":[263],"remained":[264],"elevated":[265],"until":[266],"D42,":[267],"longer":[268],"than":[269],"levels.":[271,287],"addition,":[273],"FP40/TP40":[275],"ratio":[276],"was":[277],"significantly":[278],"reduced":[279],"onwards,":[282],"Neither":[288],"nor":[292],"observed":[300],"group.":[304],"Treatment":[305],"elicits":[310],"production":[312],"increase":[318],"suggesting":[324],"positive":[326],"action":[327],"its":[329],"target":[330],"molecule,":[331],"makes":[333],"our":[334],"promising":[338],"candidate":[339],"for":[340],"AD":[341],"prevention":[342],"early":[344],"treatment.":[345]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-10-26T00:00:00"}